Takeda, Virgin Pulse Team to ‘Challenge’ Hemophilia Patients into Adopting Healthy Lifestyles

Takeda, Virgin Pulse Team to ‘Challenge’ Hemophilia Patients into Adopting Healthy Lifestyles
0
(0)

To help promote healthy lifestyle changes, the pharmaceutical company Takeda has enrolled some 900 patients with bleeding disorders like hemophilia in the Virgin Pulse Global Challenge.

The annual well-being Global Challenge aims to equip teams of employees with the knowledge, tools and support necessary to enhance performance and establish practices that are beneficial to them and ultimately their employers.

But this year marks the first time Virgin Pulse has enrolled people  outside the workplace in a Global Challenge program.  Virgin Pulse’s technological designs are meant to cultivate good lifestyle habits — configured to complement each workplace culture — for companies’ employees.

“We’re very excited for the patients to embark on this exciting journey together during which they will learn how small lifestyle changes can help them manage their condition and improve their overall health,” Merve Erdogan, Takeda global brand lead, said in a press release.

The Virgin Pulse effort results from Takeda’s search for new ways to support and improve the lives of people with hemophilia and von Willebrand disease.

Specifically, the company approached Virgin Pulse, hoping to engage the global hematology community, promote patient-focused values, demonstrate support for individuals with rare bleeding disorders, and encourage long-term and positive behavior changes.

Each Takeda team will have as its captain a medical professional who will monitor members’ progress and address questions or concerns. Patients all over the world will be able to share their experience and generally support each other on their own Challenge community page.

Annually, hundreds of thousands of employees worldwide compete in seven-member teams in a 100-day, round-the-world virtual journey designed to gradually enhance participants’ physical and psychological health while boosting confidence and camaraderie. In the past three years, more than 1 million people have taken part.

The challenge is comprised of different modules that feature key areas — including physical activity, nutrition, sleep, and mental well-being — for leading healthy and active lifestyles. Participants begin by tracking their daily activity as they work toward taking more than 10,000 steps daily.

This current challenge began on Oct. 16 and will wind up in January, when Takeda will report results. Go here for more information about Virgin Pulse and its programs.

More than 3 million U.S. residents have rare bleeding disorders that prevent blood from clotting properly. The conditions can lead to prolonged bleeding after injury, surgery, or physical trauma.

Mary M. Chapman began her professional career at United Press International, running both print and broadcast desks. She then became a Michigan correspondent for what is now Bloomberg BNA, where she mainly covered the automotive industry plus legal, tax and regulatory issues. A member of the Automotive Press Association and one of a relatively small number of women on the car beat, Chapman has discussed the automotive industry multiple times of National Public Radio, and in 2014 was selected as an honorary judge at the prestigious Cobble Beach Concours d’Elegance. She has written for numerous national outlets including Time, People, Al-Jazeera America, Fortune, Daily Beast, MSN.com, Newsweek, The Detroit News and Detroit Free Press. The winner of the Society of Professional Journalists award for outstanding reporting, Chapman has had dozens of articles in The New York Times, including two on the coveted front page. She has completed a manuscript about centenarian car enthusiast Margaret Dunning, titled “Belle of the Concours.”
Total Posts: 122
Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.
×
Mary M. Chapman began her professional career at United Press International, running both print and broadcast desks. She then became a Michigan correspondent for what is now Bloomberg BNA, where she mainly covered the automotive industry plus legal, tax and regulatory issues. A member of the Automotive Press Association and one of a relatively small number of women on the car beat, Chapman has discussed the automotive industry multiple times of National Public Radio, and in 2014 was selected as an honorary judge at the prestigious Cobble Beach Concours d’Elegance. She has written for numerous national outlets including Time, People, Al-Jazeera America, Fortune, Daily Beast, MSN.com, Newsweek, The Detroit News and Detroit Free Press. The winner of the Society of Professional Journalists award for outstanding reporting, Chapman has had dozens of articles in The New York Times, including two on the coveted front page. She has completed a manuscript about centenarian car enthusiast Margaret Dunning, titled “Belle of the Concours.”
Latest Posts
  • Covid-19 survey
  • gene therapy
  • World Hemophilia Day
  • SIG-001

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

Pin It on Pinterest

Share This